Frontotemporal dementia trials in Belgium
2 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleA Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN)
- Where
- Leuven
- Age
- 30 years to 75 years
- People
- 18 worldwide
- Run by
- AviadoBio Ltd
See details and how to joinNCT06064890 · EU 2023-509444-10-00 - No phaseTaking peopleUltra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders
- Where
- Leuven
- Age
- 18 years to 90 years
- People
- 300
- Run by
- Universitaire Ziekenhuizen KU Leuven
See details and how to joinNCT07509125